By a vote of 5-4, the US Supreme Court on Thursday agreed to allow the National Institutes of Health, the largest public ...

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...

The US Food and Drug Administration (FDA) has approved Dawnzera (donidalorsen) for prophylaxis to prevent attacks of ...

Nucleus RadioPharma, a next-generation contract development and manufacturing organization (CDMO) specializing in ...

Shares in Dynavax Technologies Corporation closed 5% higher Thursday after the presentation of positive top-line results from ...

The US Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid Services (CMS) are establishing the Healthcare Advisory Committee - a group of experts charged with delivering ...

Exorphia announced that it has signed a business collaboration agreement with fellow Japanese company Rohto Pharmaceutical, ...

France’s Nicox has announced that daily dosing of NCX 470 0.1%, a novel nitric oxide (NO)-donating bimatoprost eye drop, met ...

UK and USA-listed PureTech Health has sought to show the strength of its position in idiopathic pulmonary fibrosis (IPF) at the 2025 IPF Summit this week in Boston, Massachusetts.

The UK’s NHS Business Services Authority's annual 'Prescribing for Diabetes - England 2015/16 to 2024/25' report reveals that diabetes treatments now account for 15% of all NHS prescription spending, ...

Danish allergy immunotherapy specialist ALK Abello today posted financial results which pleased investors, with its shares rising 6.2% to 199.50 kroner.

Celldex Therapeutics shares fell as much as 13% on Wednesday, after it posted mixed top-line results from its ongoing Phase II study of barzolvolimab in eosinophilic esophagitis (EoE), a chronic ...